Peripheral aromatic L-amino acids decarboxylase inhibitor in parkinsonism. II. Effect on metabolism of L-2- 14 C-dopa.
D000284:Administration, Oral; D000368:Aged; D002247:Carbon Isotopes; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D003864:Depression, Chemical; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004298:Dopamine / Q000652:urine; D004357:Drug Synergism; D004837:Epinephrine / Q000652:urine; D006207:Half-Life; D006801:Humans; D006834:Hydrazines / Q000494:pharmacology*; D008297:Male; D008750:Methyldopa / Q000494:pharmacology*; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D010300:Parkinson Disease / Q000201:enzymology* / Q000378:metabolism; D010648:Phenylacetates / Q000652:urine
D002247:Carbon Isotopes; D006834:Hydrazines; D010648:Phenylacetates; D008750:Methyldopa; D004295:Dihydroxyphenylalanine; D002262:Carboxy-Lyases; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine